Background: Khat is a natural stimulant from the Catha edulis plant containing several chemical components, which can explain palpitation as a frequent symptom that develops during or after khat chewing. Aims: To study the effects of khat chewing on cardiac rhythm. Methods: We selected sixty khat-chewing Yemeni individuals and divided them into two groups: 30 were cardiac patients and the other 30 were non-cardiac individuals. All 60 individuals underwent 24 hours holter monitoring for 2 consequent days; the first was a khat-free day and the next was a khat-chewing day. The two groups were matched for age, sex, smoking habit, BSA, systolic and diastolic blood pressure. Non sustained Ventricular Tachycardia (VT) was defined as 3 or more wide QRS complexes at a rate of 120 beats/min and for a period less than 20 seconds. Results: The non-sustained VT was found on 7 (23.3%) of the 30 cardiac patients on a khat-chewing day compared to 2 patients (6.6%) on a khat-free day (p < 0.01). A significant difference was also seen among the normal individuals; 1 patient (3.3%) developed short runs of VT on a khat-chewing day compared to non VT on a khat-free day. Conclusions: 1) Serious arrhythmias occur in both cardiac and noncardiac individuals during khat chewing days although they are more prominent among cardiac patients. 2) This may indicate beta-blocker usage for high risk khat chewers before khat chewing.
Background: A retrospective study was performed to study the effect of polycythemia on the severity of coronary artery occlusions and echocardiographic characteristics among acute coronary syndrome (ACS) patients in Yemen. Methods: Tow hundred and four (204) ACS patients in Yemen who underwent coronary angiography were reviewed from January 2014 to December 2014. Results: The mean age of Polycythemia ACS patients was significantly lower than normal hemoglobin patients (54.59 years vs. 57.08 years; p < 0.000). The prevalence of hyperlipidaemia for Polycythemia ACS patients was significantly higher (55.1% and 39.9%; p < 0.000). Also the prevalence of history of coronary artery disease (CAD) for Polycythemia ACS patients was significantly higher (21.3% vs.10.6%; p < 0.000). The prevalence of hypertension (HTN), diabetes mellitus (DM), and tobacco smoking were comparable at both groups. Left ventricle ejection fraction (LVEF) for Polycythemia ACS patients was significantly lower (47.9% and 52.8%; adjust; p < 0.000). Normal coronary angiography for non-Polycythemia ACS patients was non-significantly higher (9.6% vs. 7.6%). Single vessel occlusion for non-Polycythemia patients was higher (41.9% vs. 29.6%). Two vessel occlusions were comparable for patients at both groups. Three vessel occlusions for Polycythemia ACS patients were significantly higher (37.2% vs.23.6%). Conclusions: Acute coronary syndrome occurs at a younger age for Polycythemia ACS patients. Polycythemia ACS patients are also more likely to have hyperlipedaemia and history of CAD. Impaired LVEF occurs more commonly in Polycythemia ACS patients. The ACS patients who have Polycythemia were associated with more coronary arteries occlusions. Three vessel occlusion and circumflex coronary artery occlusions occur more commonly among Polycythemia ACS patients. We noted association between high percentages of hemoglobin and coronary complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.